{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:29:19Z","timestamp":1760887759387},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1385\/jcd:8:3:293","type":"journal-article","created":{"date-parts":[[2005,7,30]],"date-time":"2005-07-30T10:20:23Z","timestamp":1122718823000},"page":"293-297","source":"Crossref","is-referenced-by-count":28,"title":["Reproducibility of DXA Estimations of Body Fat in HIV Lipodystrophy"],"prefix":"10.1016","volume":"8","author":[{"given":"Rodrigo B.","family":"Cavalcanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Raboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9170","key":"10.1385\/JCD:8:3:293_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1385\/JCD:8:3:293_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11892-002-0070-x","article-title":"HIV-associated lipodystrophy: description, pathogenesis, and molecular pathways","volume":"2","author":"Mallon","year":"2002","journal-title":"Curr Diab Rep"},{"issue":"9119","key":"10.1385\/JCD:8:3:293_bib3","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"issue":"9359","key":"10.1385\/JCD:8:3:293_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case-control study","volume":"361","author":"Carr","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1385\/JCD:8:3:293_bib5","first-page":"89","article-title":"HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities","volume":"3","author":"Moyle","year":"2002","journal-title":"HIV Clin Trials"},{"issue":"2","key":"10.1385\/JCD:8:3:293_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jinf.2002.1103","article-title":"HIV-associated lipodystrophy syndrome: assessment and management","volume":"46","author":"Bodasing","year":"2003","journal-title":"J Infect"},{"issue":"2","key":"10.1385\/JCD:8:3:293_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1468-1293.2002.00105.x","article-title":"Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors","volume":"3","author":"Tsekes","year":"2002","journal-title":"HIV Med"},{"issue":"7","key":"10.1385\/JCD:8:3:293_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1385\/JCD:8:3:293_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00126334-200301010-00015","article-title":"Agreement analysis of variables involved in lipodystrophy syndrome definition in HIV-infected patients","volume":"32","author":"Belloso","year":"2003","journal-title":"J Acquired Immune Defic Syndrome"},{"issue":"1","key":"10.1385\/JCD:8:3:293_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s001980170157","article-title":"Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis","volume":"12","author":"Phillipov","year":"2001","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1385\/JCD:8:3:293_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/JCD:5:1:035","article-title":"Reproducibility of DXA in obese women","volume":"5","author":"Cordero-MacIntyre","year":"2002","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1385\/JCD:8:3:293_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF01774016","article-title":"Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques","volume":"5","author":"Gluer","year":"1995","journal-title":"Osteoporos Int"},{"key":"10.1385\/JCD:8:3:293_bib13","series-title":"Bone Densitometry in Clinical Practice: Application and Interpretation","author":"Bonnick","year":"1998"},{"issue":"2","key":"10.1385\/JCD:8:3:293_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"10.1385\/JCD:8:3:293_bib15","unstructured":"McComsey G, Lonergan T, Fisher R, et al. 2002 Improvements in lipoatrophy (LA) are observed after 24 weeks when stavudine (d4T) is replaced by either abacavir (ABC) or zidovudine (ZDV). 9th Conference on Retroviruses and Opportunistic Infection."},{"issue":"1","key":"10.1385\/JCD:8:3:293_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1310\/WRL8-DWH1-7VQL-AK81","article-title":"Centralized assessment of dual-energy X-ray absorptiometry (DXA) in multicenter studies of HIV-associated lipodystrophy","volume":"4","author":"Smith","year":"2003","journal-title":"HIV Clin Trials"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469500660320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469500660320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T22:24:58Z","timestamp":1548282298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109469500660320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S109469500660320X"],"URL":"https:\/\/doi.org\/10.1385\/jcd:8:3:293","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}